Clinical trial

Efficacy Confirmation Study of CDP870 in Early Rheumatoid Arthritis

NCT01451203

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-10-11

PhasePHASE3

Study timeline

Study start (actual)2011-10-11Date precision: day

Registry last updated2024-12-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

PlaceboDRUG

CZPDRUG

methotrexate (MTX)DRUG

Sponsors & collaborators

Astellas Pharma Inclead sponsor

UCB Japan Co. Ltd.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01451203 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.